Northwest Biotherapeutics Inc (NASDAQ:NWBO) - Share price - Overview

Stock Report

Northwest Biotherapeutics Inc NWBO

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap36.12Mil
52-Wk Range-
Yield %-
ISINUS66737P6007
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.811.451.74
Operating Income-55.47-101.14-126.28
Net Income-65.79-135.63-114.74
Basic EPS-2.00-2.29-1.48
Avg. Diluted Shares Outstanding335978
Balance Sheet
Current Assets18.6514.6424.10
Non Current Assets0.1443.8046.70
Total Assets18.7858.4470.80
Current Liabilities19.6968.8864.79
Total Liabilities28.6093.4775.47
Total Equity-9.82-35.03-4.68
Cash Flow
Operating Cash Flow-37.80-54.58-78.61
Capital Expenditure--33.73-6.75
Free Cash Flow--88.30-85.36

In millions, except "Basic EPS". Currency is USD.

Company Profile

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.

Sector

Healthcare

Industry

Biotechnology

Fiscal Year Ends

December

Employees

12
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)31.09
EPS Growth (3 year avg)-
Operating Margin % TTM-7,261.87
Net Margin % TTM-6,598.10
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.